Suchergebnisse - "Frisell, Thomas"

PubPharm (150)

71

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

enthalten in: JAMA neurology | 2020

von Luna, G. | Alping, P. | Burman, J. | +13

CommentIn: J Neurol. 2020 May;267(5):1567-1569. - PMID 32303837

72

Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients

enthalten in: Annals of Neurology | 2020

von Alping, P. | Askling, J. | Burman, J. | +13

73

Violent crime among Swedish military veterans after deployment to Afghanistan : a population-based matched cohort study

enthalten in: International journal of epidemiology | 2019

von Pethrus, C. | Frisell, T. | Reutfors, J. | +5

74

Comment on : Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register: reply

enthalten in: Rheumatology (Oxford, England) | 2019

von Frisell, T. | Askling, J.

CommentOn: Rheumatology (Oxford). 2019 Jan 21;:null. - PMID 30668875

75

Comment on : Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register: reply

enthalten in: Rheumatology (Oxford, England) | 2019

von Frisell, T. | Askling, J.

CommentOn: Rheumatology (Oxford). 2019 Jan 21;:null. - PMID 30668875

76

Siblings of patients with rheumatoid arthritis are at increased risk of acute coronary syndrome

enthalten in: Annals of the rheumatic diseases | 2019

von Westerlind, H. | Holmqvist, M. | Ljung, L. | +2

CommentIn: Ann Rheum Dis. 2020 May;79(5):e49. - PMID 30842124

77

Validation of the Swedish Multiple Sclerosis Register : Further Improving a Resource for Pharmacoepidemiologic Evaluations

enthalten in: Epidemiology (Cambridge, Mass.) | 2019

von Alping, P. | Piehl, F. | Langer-Gould, A. | +2

78

Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA : results from the nationwide Swedish register

enthalten in: Rheumatology (Oxford, England) | 2019

von Frisell, T. | Dehlin, M. | Di Giuseppe, D. | +13

CommentIn: Rheumatology (Oxford). 2019 Aug 1;58(8):1507. - PMID 30838408

79

Comparative effectiveness of rituximab relative to IFN-β or glatiramer acetate in relapsing-remitting MS from the Swedish MS registry

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2018

von Spelman, T. | Frisell, T. | Piehl, F. | +1

80

Concordance of Non-Low-Risk Disease Among Pairs of Brothers With Prostate Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2018

von Jansson, F. | Drevin, L. | Frisell, T. | +3